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Abstract
Meta-analysis of multiple genome-wide association studies (GWAS) is effective for detect-
ing single or multi marker associations with complex traits. We develop a flexible procedure
(“STAMP”) based on mixture models to perform region based meta-analysis of different phe-
notypes using data from different GWAS and identify subsets of associated phenotypes. Our
model framework helps distinguish true associations from between-study heterogeneity. As a
measure of association we compute for each phenotype the posterior probability that the ge-
netic region under investigation is truly associated. Extensive simulations show that STAMP
is more powerful than standard approaches for meta analyses when the proportion of truly
associated outcomes is ≤ 50%. For other settings, the power of STAMP is similar to that of
existing methods. We illustrate our method on two examples, the association of a region on
chromosome 9p21 with risk of fourteen cancers, and the associations of expression of quanti-
tative traits loci (eQTLs) from two genetic regions with their cis-SNPs measured in seventeen
tissue types using data from The Cancer Genome Atlas (TCGA).
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1 Introduction
Sometimes it is of interest to assess the association of genetic variation within a pre-specified region
with different, possibly related, phenotypes, and to quantify heterogeneity of the associations. For
example, Li and others (2014) recently studied the associations of single nucleotide polymorphisms
(SNPs) in a chromosome 9p21 region with eight cancers that includes interferon genes and several
tumor suppressor genes, from eight genome-wide association (GWAS) studies. The authors con-
ducted SNP-level analyses for each cancer and used a subset-based statistical approach (ASSET)
(Bhattacharjee and others , 2012) to combine SNP-level p-values across cancers. In another exam-
ple, Flutre and others (2013) proposed methods to assess single SNP associations between with
expression quantitative trait loci (eQTL) expression measured in multiple tissues.
Standard meta-analytic approaches to combine summary information from a single SNP are not
powerful when the SNP has an effect in only a subset of phenotypes or in opposite directions for
some phenotypes. Multiple methods are available to assess the association of common genetic vari-
ants such as GWAS SNPs with risk of multiple phenotypes measured on the same samples (Yang
and others , 2016; O’Reilly and others , 2012; van der Sluis and others , 2013) but only few methods
are available based on summary statistics. ASSET and CPBayes (Majumdar and others , 2017) use
summary statistics to identify subsets of studies associated with a particular SNP, but they do not
allow one to readily combine information from multiple SNPs in a locus. Information stemming
from linkage disequilibrium (LD) is not utilized when analyzing each SNP in a region separately.
Several adaptive gene-based approaches are available to study multiple SNPs simultaneously (Tang
and Ferreira, 2012; Van der Sluis and others , 2015; Kwak and Pan, 2017) and accommodate hetero-
geneous SNP effects, or effects that present in some studies. However, these approaches only give
global measures of association and do not identify the subset of associated studies.
We therefore propose a new approach to explore genetic heterogeneity of associations for a ge-
nomic region with different phenotypes and to identify a subset of phenotypes that are associated
with that region. First, for each phenotype separately, we combine the SNP specific association
estimates using an aggregated level test statistic. We then assume that the test statistics arise
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from a mixture distribution with two components, one under the null model of no association of
the study specific phenotype with the genetic region, and one distribution assuming that there is
an association. We use a hierarchical model to describe SNP effects (Section 2) that can accommo-
date varying levels of between-phenotype heterogeneity. We then test if the mixture distribution
provides a better fit to the region specific test statistics from all studies than a single component
density, estimate the parameters of the mixture and compute posterior probabilities that a partic-
ular phenotype is associated with the genomic region (Section 3). As an illustration, we analyzed
the association of the 9p21 region (using GWAS SNPs) with various cancers, and the genetic asso-
ciations of eQTLs from two genetic regions measured in seventeen different tissue types (Section 4).
We study our method in simulations (Section 5) and compare its power to existing meta analytic
approach, before closing with a discussion (Section 6).
2 Data and models
2.1 Association models
We now describe the model assumed to govern the association between a particular phenotype Ys
and genotypes Xs = (Xs1, . . . , Xsps)
′ for ps SNPs measured in a genomic region, where Xsi = 0, 1, or
2 denotes the number of minor alleles at locus i, i = 1, . . . , ps. Here we allow for different numbers
of SNPs measured in a genomic region for different phenotypes. We consider the generalized linear
model (GLM) setting (see e.g. McCullagh and Nelder, 1989), and assume that the conditional
expectation of Ys given Xs is
EF (Ys|Xs,γs) = h(γs0 +
ps∑
i=1
γsiXsi) = h(γs0 + γ
′
sXs), (1)
where h is a known function and (γs0,γs) a vector of p + 1 association parameters for the SNP.
If the k-th SNP is not associated with Ys, γsk = 0. Additional covariates Zs = (Zs1, . . . , Zsq)
′ can
easily be accommodated in model (1) through EF (Ys|Xs, γs0,γs,αs) = h(γs0 + γ ′sXs + α′sZ). We
assume that F is a probability density or mass function from the exponential family (McCullagh
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and Nelder, 1989).
2.2 Properties of estimates obtained from marginal SNP models
In GWAS studies the estimate βˆsj for the association of the jth SNP with outcome Ys is typically
obtained by maximizing a marginal likelihood that only includes the genotype Xsj for the jth SNP
in the specification of the mean function instead of the whole vector Xs,
EG(Ys|Xs, βs0j, βsj) = h(βs0j + βsjXsj), (2)
where h denotes the same function as in (1). If additional covariates Zs are available, (2) can be
extended to EG(Ys|Xs, βs0j, βsj, ζs) = h(βs0j + βsjXsj + ζ ′sjZs). We use the subscript G to denote
the misspecified marginal mean probability model that uses only individual SNP genotypes. We
show in the Appendix 1.A that, conditional on γs, the estimate βˆsj based on (2) converges to βsj
that satisfies the equation
βsj =
∑ps
i=1 γsiCov(Xsi, Xsj)
V ar(Xsj)
, (3)
where γsi is the true associate parameter for SNP i in (1), when h is the identity link function h
or the logistic link, under both, prospective and retrospective sampling, i.e. for case-control data
assuming rare disease. As can be seen directly from (3), when there is no association, i.e. γsi = 0
for all SNPs i = 1, ..., ps, then also βsi = 0 for all i = 1, ..., ps, and when the SNPs are uncorrelated,
then βsi = γsi. Using the matrix Ωs defined element-wise as
[Ωs]ij =
Cov(Xsi, Xsj)
V ar(Xsi)
for i, j = 1, ..., ps, (4)
and conditional on the vector of true effects γs, the estimates βˆs = (βˆs1, . . . , βˆsps) from the marginal
model (2) have the following limiting distribution
βˆs|γs ∼ N(βs,Σs) = N(Ωsγs,Σs), (5)
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where Σs = Cov(βˆs|γs), which is typically not known for the marginal estimates. For small effects
γs, following Hu and others (2013),
Σs ≈ DsΥsDs, (6)
where Υs = Cor(Xs) is the correlation matrix between the p SNPs that is assumed to be known
and Ds = diag(σs1, . . . , σsps) is a diagonal matrix of standard error estimates σsj of βˆsj, j = 1, ..., ps.
Letting VXs = diag {V ar(Xs1), . . . , V ar(Xsps)}, Υs = V 1/2Xs ΩsV −1/2Xs . Yang and others (2012) derived
similar results to (3) using a least squares approach for the linear model and extended it to case-
control data using a liability threshold model.
2.3 Hierarchical model for SNP effects
We assume that the study and phenotype specific association parameters γs in (1) arise from a
multivariate normal distribution,
γs = (γs1, ..., γsps)
′ ∼ N(µs,Λs), s = 1, . . . , S, (7)
where µs = (µs1, . . . , µsps)
′ and τ s = (τs1, . . . , τsps)
′ denote the phenotype specific association
parameters and Λs = diag(τ s) is a diagonal matrix. The components µsj and τsj, j = 1, . . . , ps,
of µs and τ s, are assumed to be independent random draws from two possible super-populations,
one for associated phenotypes and one for phenotypes that exhibit no associations with the region
(Figure 1). We do not assume any specific distributions for the super-populations, we only describe
them through their moments.
We distinguish between phenotype specific mean SNP effects µs and study specific effects γs
as different studies for the same genotype could have different ”true” associations, e.g. due to
differences in unmeasured confounders. If there are multiple studies for each phenotype, then
(µs, τ s) can be estimated from available data. Otherwise, only the super-population parameters in
the top hierarchical layer can be estimated.
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Super-population distribution for SNP effects, H(µ, τ) with E(µ4) < ∞ and E(τ2) < ∞
Phenotype specific parameters µsj and τsj , j = 1, . . . , ps
for the ps SNPs are iid draws from H, resulting in
µs = (µs1, . . . , µsps)
′, τ s = (τs1, . . . , τsps)
′
Study specific parameters for phenotype s:
(γs1, ..., γsps)
′ = γs|(µs, τ s) ∼ N(µs,Λs = diag(τ s))
Study specific marginal estimates
βˆs|γs ∼ N(Ωsγs,Σs)
1
Figure 1: Hierarchical model set-up for study specific estimates for particular phenotype s
Based on equations (5) and (7), the conditional distribution of βˆs is
βˆs|(µs, τ s) ∼ N (Ωsµs,ΩsΛsΩ′s + Σs) , (8)
where Σs is given in (6). To recover the true association parameters µs and Λs, we rotate the
estimates, to obtain
βˆ
∗
s|(µs, τ s) = Ω−1s βˆs|(µs, τ s) ∼ N (µs,Λs + Σ∗s) , (9)
where Σ∗s = Ω
−1
s ΣsΩ
′−1
s . Under local alternatives, i.e. small effects γs, Tang and Lin (2014); Yang
and others (2012) showed that Σ∗s ≈ csNsCov(X)−1, where cs denotes the residual variance under
the null model of no genetic associations, and Ns is the sample size of study s.
For those Ys that exhibit no associations with the genetic region, we consider two different
assumptions for the super-population that gave rise to µs and τ s, termed “null models”. Under
the first one, the “strong null model (mst0 )”, that has been used for meta analysis of single or
multiple SNPs (Han and Eskin, 2011; Lee and others , 2013; Tang and Lin, 2014; Shi and Lee,
2016), µs ≡ 0, and τ s ≡ 0 for all SNPs in a region, and thus γsj ≡ 0, j = 1, ..., ps, without any
variation. Thus the first three levels in the hierarchical model in Figure 1 can be collapsed, and it
follows that βˆs|(µs, τ s)
mst0∼ N (0,Σs) . Several super-population models are appropriate when mw0 is
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used for those Ys for which there are associated SNPs in the genetic region. The first is to assume
that E(µsj) = 0 and V ar(µsj) + V ar(τsj) 6= 0. This setup has been used previously for variance
component testing in random effect models (e.g. Lin, 1997) and for het-SKAT(Lee and others ,
2013). Alternatively, one could let E(µsj) 6= 0 and V ar(µsj) + V ar(τsj) = 0, which is assumed in
fixed effect meta analysis (Cochran, 1954). Han and Eskin (2011); Tang and Lin (2014) studied a
combination of two models, E(µsj) 6= 0 or V ar(µsj) + E(τsj) 6= 0.
Under the second, weaker set of assumptions for the null super-population model (mw0 ), we only
assume that µj ≡ 0 for all SNPs j. Thus, under mw0 , for some SNPs, γsj 6= 0 due to different LD in
different populations, measurement error or other sources of confounding. The appropriate model
for phenotypes with associations in the region, that has been used in the context of meta-analysis
(e.g. Han and Eskin, 2011; Tang and Lin, 2014; Shi and Lee, 2016), assumes that E(µsj) 6= 0 or
V ar(µsj) 6= 0. Here, we require the availability of a ’negative’ control study, i.e. a phenotype Ys
that is known not to be associated with the genetic region, to be able to distinguish between sources
of variation in the genetic effects, i.e. between V ar(µsj) and E(τsj).
To summarize, the distributions of the rotated estimates of effect sizes in (9) simplify to
βˆ
∗
s|(µs, τ s)
mst0∼ N (0,Σ∗s) and βˆ
∗
s|(µs, τ s)
mw0∼ N (0,Λs + Σ∗s) , (10)
under the two models of no genetic associations.
3 Assessing the association of a genetic region with multi-
ple phenotypes
We assume now that we have one study for each phenotype Ys. For each phenotype Ys we combine
the linearly transformed values Σ∗−1s βˆ
∗
s using a linear or quadratic statistic Ts, which are asymptot-
ically equivalent to variance component tests to assess high dimensional alternatives (Derkach and
others , 2014; Tang and Lin, 2014; Lee and others , 2012)
Linear tests have good power if a large proportion of SNPs in the region under consideration
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are associated and have effects in the same direction, while quadratic test statistics are robust to
different signs of effect estimates and are more powerful when the proportion of associated SNPs
in the region is small (e.g. Derkach and others , 2014). Under heterogeneity of associations of
phenotypes Ys, s = 1, . . . , S, we assume that Ts arises from a mixture model that we present next.
3.1 Mixture model
If only a proportion of the phenotypes Ys, s = 1, . . . , S, are associated with the genetic region
under investigation, we assume test statistics Ts arise from a mixture distribution, due to two super
populations giving rise to the observed estimates,
f(Ts) ∼ (1− pi)ϕ0(Ts) + piϕ1(Ts). (11)
In (11), ϕ0 denotes the density of Ts under the null model of no association of that particular
genetic region with Ys, and ϕ1 is the density when the region is associated with the phenotype.
The mixing proportion pi can be interpreted as the prior probability of a phenotype having genetic
associations. Functional information can be incorporated into pi, e.g. by using a covariate Zs that
captures biologically relevant data through pis = exp(δ0 + δ1Zs)/ {1 + exp(δ0 + δ1Zs)}.
For both, our linear and quadratic summary statistics Ts, ϕ0 and ϕ1 can be approximated
by normal densities. We discuss the parameterization of Ei(Ts) and V ari(Ts), i = 0, 1, and the
estimation of model (11) in detail in Sections 3.2 and 3.3, respectively and summarize it in Table 1.
The basic steps for assessing heterogeneity of associations for phenotypes Ys, s = 1, . . . , S, and
for identifying the subset of phenotypes associated with a genomic region are as follows.
1. Use a likelihood ratio test (LRT) to test if the statistics Ts, s = 1, . . . , S, arise from the mixture
model in (11) (H1), or from a single density, ϕ0 (H0). For testing under the weak null model,
a ”control” study, i.e. a study under mw0 is required for identifiability. Details on the testing
are given in Section 3.4.
2. If there is evidence of heterogeneity based on the LRT, use the mixture model to compute
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Table 1: Summary of models and parameters estimated under a single component model, ϕ0 (H0,),
or a mixture distribution (H1) that indicates heterogeneity of associations. We let µc = µ− E(µ).
TL and TQ denote linear and quadratic test statistics under model (11)
Parameters estimated under
Test
Statis-
tic
H0 (single den-
sity)
H1 (mixture, i.e. heterogeneity)
”Weak” null model: µ ≡ 0, βˆ∗s|µs, τ s ∼ N (0,Λs + Σ∗s)
TL E(τ) pi,E(µ), E(τ), V ar(µ)
TQ E(τ), V ar(τ) pi,E(µ), E(µ2c), E(µ
3
c), E(µ
4
c), E(τ), V ar(τ)
”Strong” null model: µ ≡ 0 and τ ≡ 0, βˆ∗s|µs, τ s ∼ N (0,Σ∗s)
TL − pi,E(µ), eζ = E(τ) + V ar(µ)
TQ − pi, eζ = E(τ) + E(µ2c), E(µ), E(µ3c),
eψ = 3V ar(τ) + V ar(µ2c) + 2E(τ)
2 +
4E(τ)E(µ2c)
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the probability that the region is associated with a particular phenotype Ys, i.e. the posterior
probability
pˆs = P (Ts arises from ϕ1|T1, . . . , TS) = pˆiϕˆ1(Ts)
(1− pˆi)ϕˆ0(Ts) + pˆiϕˆ1(Ts) .
3. If pˆs > p
∗ for some prespecified threshold, e.g. p∗ = 0.5, then phenotype Ys is considered to
be associated with the region.
3.2 A linear summary test statistic, TLs
We first propose and study a linear test statistic to combine transformed SNP effects,
TLs =
1′Σ∗−1s βˆ
∗
s
{1′diag(Σ∗−1s )1}1/2
. (12)
As βˆ∗sj is asymptotically normally distributed, T
L
s conditional on µs and Λs is normally distributed
with moments
Eµs,τ s(T
L
s ) =
1′Σ∗−1s µs
{1′diag(Σ∗−1s )1}1/2
and V arµs,τ s(T
L
s ) =
1′Σ∗−1s 1 + 1
′Σ∗−1s ΛsΣ
∗−1
s 1
{1′diag(Σ∗−1s )1}1/2
. (13)
The unconditional mean and variance of TLs are
E(TLs ) =
1′Σ∗−1s E(µ)
{1′diag(Σ∗−1s )1}1/2
and V ar(TLs ) =
1′Σ∗−1s 1 + {E(τ) + V ar(µ)}1′Σ∗−2s 1
{1′diag(Σ∗−1s )1}1/2
. (14)
The numerator of the variance of TL under the strong null model is 1′Σ∗−1s 1 and under the weak
null model it is 1′Σ−1∗s 1 + E(τ)1
′Σ∗−2s 1. Under the alternative model E(T
L
s ) and V ar(T
L
s ) in (14)
do not simplify further. For the LRT based on the weak null model we estimate four parameters
under the alternative model and one under the null model (see Table 1).
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3.3 A quadratic summary test statistic, TQs
The linear test statistic TLs in Section 3.2 has the disadvantage that it is sensitive to the directions
of the associations, i.e. the signs of the β∗si, i = 1, . . . , ps, and is not powerful when signal comes
from only a few SNPs. To overcome these limitations we also combine the ps SNP estimates for
phenotype s using a quadratic form,
TQs = βˆ
∗′
s Σ
∗−1
s WsΣ
∗−1
s βˆ
∗
s, (15)
where Ws is a preselected weight matrix. Since the βˆ
∗
s have an asymptotically multivariate normal
distribution, TQs is a linear combination of independent non-central chi-squared random variables
(Derkach and others , 2014; Wu and others , 2011) where the non-centrality parameters depend on
µs and τ s. Within the normal mixture framework in Section 3.1 we utilize that if the number ps
of SNPs is large, TQs is approximately normally distributed with mean E(T
Q
s )/
√
ps and variance
V ar(TQs )/ps. Note that for Ws = Σ
∗
s, T
Q
s corresponds to the Hotelling’s test statistic (Derkach and
others , 2014; Tang and Lin, 2014). Here, we let Ws = I, where I denotes identity matrix. This
choice may improve power because it assigns bigger weights to the largest principal components of
Cov(X), which are likely to explain a large proportion of the phenotypic variation. For small γi,
TQs is asymptotically equivalent to the C-alpha test for rare variants under local alternatives (Neale
and others , 2011). Other choices of Ws based on MAFs were proposed in Wu and others (2011)
and Basu and Pan (2011) in the context of rare variant analysis.
Based on the conditional moments given in Appendix 1.B, the unconditional moments are
E(TQs ) = tr(Σ
∗−1
s ) + e
ψtr(Σ∗−2s ) + {E(µ)}2 1′Σ∗−2s 1, (16)
where eψ = V ar(µ) + E(τ) quantifies the variability in genetics effects due to within locus and
between study heterogeneity and eζ = 3V ar(τ) + V ar
[{µ− E(µ)}2] + 2 {E(τ)}2 + 4V ar(µ)E(τ)
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is used to capture the higher order moments of the super-population. Letting µc = µ− E(µ),
V ar(TQs ) = 2tr(Σ
∗−2
s ) + 4tr(Σ
∗−3
s )e
ψ + 41′Σ∗−4s 1 {E(µ)}2 eψ
+ 2tr(Σ∗−4s )e
2ψ + 4 {E(µc)}3E(µ)1′Σ∗−2s diag(Σ∗−2s )
+ tr
{
Σ−2s diag(Σ
∗−2
s )
} (
eζ − 2e2ψ)+ 41′Σ∗−3s 1 {E(µ)}2 . (17)
In summary, (16) and (17) depend on the following moments of the distribution of µs and τ s:
E(µ), E(µ3c), E(µ
2
c) = V ar(µ), E(µ
4
c), E(τ) and V ar(τ) (see Table 1). The moments of T
Q
s for
a general matrix Ws are given in the Appendix 1.B. Under the strong null model, (16) and (17)
simplify to E0(T
Q
s ) = tr(Σ
∗−1
s ) and V ar0(T
Q
s ) = 2tr(Σ
∗−2), and under the weak null model to
E0(T
Q
s ) = tr(Σ
∗−1
s )+E(τ)tr(Σ
∗−2
s ) and V ar0(T
Q
s ) = 2tr(Σ
∗−2
s )+4tr(Σ
∗−3
s )E(τ) +2tr(Σ
∗−4
s )E(τ)
2+
3tr {Σ−2s diag(Σ∗−2s )}V ar(τ).
The identifiability of the parameters in the first two moments of TQs under either null model
can be seen immediately. Here, we thus discuss identifiability of ζ, ψ, E(µ) and E(µ3c) from (16)
and (17) under the model for association. The signs of E(µ) and E(µ3) are not identifiable. The
identifiability of ψ and E(µ)2 is ensured from the form of E(TQs ) if there are at least two studies
with different matrices Σ∗−2s . Similarly E(µ
3
c) and ζ are identifiable from the second moments of
TQs if there are at least two studies with different matrices Σ
∗−2
s diag(Σ
∗−2
s ). If tr(Σ
∗−2
s ) = 1
′Σ∗−2s 1
(e.g. the SNPs are independent), we cannot distinguish between effects of E(µ2) and E(τ). This
special case is further discussed in Appendix 1.C.
3.4 Testing for heterogeneity of associations among studies
Testing for heterogeneity of associations among phenotypes Ys with the proposed statistics corre-
sponds to assessing if TLs or T
Q
s arise from a single density or a mixture of densities. We thus use a
LRT statistic for TLs or T
Q
s and propose two parametric bootstrap procedures to compute p-values,
one for the strong and one under the weak null model.
For testing under the strong null model, for each bootstrap replication r, we generate rotated
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estimates βˆ
∗
s(r) ∼MVN(0,Σ∗s)s for s = 1, ..., S. Then we recalculate the test statistic and obtain a
new value of LRT (r) based on the vector of TQs (r) or T
L
s (r). When testing with the weak null model,
however, the replication procedure is more complicated, as the distribution of the marginal estimates
depends on the diagonal matrix Λs, i.e. the second moment of the τi. We consider two different
procedures for TQs and T
L
s . For the linear statistic, we directly generate T
L
s (r) from a normal
distribution with mean 0 and covariance matrix
{
1′Σ∗−1s 1 + Eˆ(τ)1
′Σ∗−2s 1
}
/ {1′diag(Σ∗−1s )1}1/2,
where Eˆ(τ) is estimated from moments of the linear statistic (14).
We do not generate TQs directly from a normal distribution, because when ps, the number of
SNPs is small, or LD is high in the region, the normal approximation may not be appropriate.
Instead, we generate the estimates of the effect sizes as functions of τ as follows. We estimate E(τ)
and E(τ 2) by solving two unbiased estimation equations under the restriction that the estimates
cannot be negative,
S∑
s=1
ps∑
j=1
{
βˆ2sj
σ2sj
− 1− E(τ)
σ2sj
}
= 0 and
S∑
s=1
ps∑
j=1
{
βˆ4sj
σ4sj
− 1− 3E(τ
2)
σ4sj
− 6E(τ)
σ2sj
}
= 0, (18)
to obtain Vˆ (τ) = max
{
0, Eˆ(τ 2)− Eˆ(τ)2
}
. We then draw the elements of the diagonal matrix Λs(r)
from an inverse-gamma distribution with the first two moments equal to Eˆ(τ) and Eˆ(τ 2), generate
transformed marginal estimates βˆ
∗
s(r) ∼ N {0,Σ∗s + Λs(r)} and calculate the quadratic statistics
TQs (r).
For both procedures, p-values are calculated as pˆ = 1/R
∑R
r=1 I {LRT (obs) ≤ LRT (r)}, where
I denotes the indicator function.
4 Data examples
We illustrate our method on two data examples, one that uses binary phenotypes and one based
on continuous Ys.
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4.1 Association of a chromosome 9p21 region with multiple cancers
We used data from GWAS studies in dbGaP to assess the association of a region on chromosome
9p21 with fourteen different cancers (see Supplemental Table S1). To assess the impact of LD on
the approach, we applied LD pruning of the SNPs with LD thresholds (e.g. pairwise LD) 0.25,
0.5 and 0.75. As we had access to individual level data from all studies, we first estimated the
log-odds ratio βˆsj and standard error for each SNP j for each cancer s separately, from logistic
regression models adjusted for gender, age, study and 10 principle component scores to control for
population stratification. SNPs were coded as 0, 1,or 2 minor alleles in these models. Additionally
we computed phenotype-specific estimates Ωˆs in (4). We then computed p-values for T
L and TQ
under the mixture model (TLMix and T
Q
Mix). For comparison, we also computed p-values for tests
TLHetmeta and T
Q
Hetmeta under the assumption of a single density, given by
TLHetmeta =
∑S
s=1 T
L
s /V ar0(T
L
s )√∑S
s=1 1/V ar0(T
L
s )
, (19)
where V ar0(T
L
s ) is calculated under the strong null model and
TQHetmeta =
S∑
s=1
βˆ
∗′
s Σ
∗−2
s βˆ
∗
s =
S∑
s=1
TQs , (20)
which is Het-MetaSKAT (Tang and Lin, 2014; Lee and others , 2013) with weights set to 1. To test
under the weak null model, we used pancreatic cancer as a negative control.
Results from the various methods are presented in Table 2 for the LD threshold 0.5. The
lowest single study p-value for the linear statistic TLs was 0.21, observed for breast cancer. When
we tested the strong null with the linear TLMix and single density assumption (T
L
Hetmeta), we did
not detect statistical significant associations between the genetic region and any of cancers, and
the overall p-values were 1 and 0.7, respectively. In contrast, the quadratic test TQs detected
statistically significant association between the region and esophageal cancer, with p-values 0.0001
and suggestive p-values for stomach cancer and glioma but not significant after multiple testing
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correction. Using standard meta analysis with TQHetmeta, we did not detect an overall association.
However, TQMix detected associations between the region and esophageal and stomach cancers, with
a posterior probabilities pˆs 1 and 0.61 respectively, and provided suggestive evidence for glioma
(pˆs = 0.36).
Table 2: Results of across-cancer meta analysis with fourteen cancers from case-control studies. The
number of SNPs is total number of SNPs in the region with MAF greater than 5% and pairwise
LD < 50%. Posterior probabilities were calculated from TLMix and T
Q
Mix and p-values for T
L
Hetmeta
and TQHetmeta under a single density, ϕ0.
Linear Test, TL Quadratic Test, TQ
Cancer Number
of
cases/controls
#
SNPs
PosteriorP-
value
PosteriorP-
value
Bladder 2071/6738 86 0 0.40 0.01 0.31
Glioma 440/4631 83 0 0.50 0.36 0.08
Breast 1035/1160 83 0 0.21 0.08 0.13
Colon 109/5693 85 0 0.96 0.00 0.58
Endometrial890/713 79 0 0.42 0.01 0.38
Esophagus 1956/2093 98 0 0.89 1.00 0.0001
Kidney 1288/6455 86 0 0.98 0.01 0.87
Lung 4786/7685 86 0 0.33 0.01 0.72
NHL 1599
/6209
78 0 0.63 0.01 0.65
Ovary 278/650 87 0 0.31 0.05 0.60
Prostate 5217/5043 82 0 0.69 0.01 0.23
Stomach 1761/2093 100 0 0.34 0.61 0.02
Testis 457/576 117 0 0.41 0.03 0.92
Pancreas 417/5693 84 0 0.28 0.00 0.62
TLMix T
L
Hetmeta T
Q
Mix T
Q
Hetmeta
Global
P-value
1 0.7 0.008 0.16
For the LD threshold 0.5, the parameters in the mixture model were pˆi = 0.2, Ê(µ) = 0.0018,
and Ê(µ3c) = −0.0005. The small value of Ê(µ) indicates that signal is likely sparse in the region.
We observed extremely low estimates of the heterogeneity parameters eψˆ = 1.6 × 10−3 and eζˆ =
1.5 × 10−8 because only two cancers, esophagus and stomach had a strong association with the
region. The same results were observed for SNPs selected using the LD threshold of 0.25 and 0.75
(see Supplemental Tables S4 and S5). Results for stomach, esophagus cancers and glioma were
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previously reported to be associated with the region (Li and others , 2014).
Lastly, we tested under the weak null model with TLMix and T
Q
Mix using pancreatic cancer as a
negative control outcome. Similarly to the results for testing under the strong null model, only TQMix
under the mixture model detected the association with esophageal cancer and provided suggestive
evidence for stomach cancer (Supplemental Table S6).
4.2 Associations of two genetic regions with expression of quantitative
trait loci (eQTL) data from multiple tissues
To illustrate our method for continuous Ys, we used genotype and total gene expression data based
on RNA sequencing for 17 tumor tissues from The Cancer Genome Atlas (TCGA) project. Details
on data processing are described in Supplementary Materials of Heller and others (2017). Here we
focused on eQTL data from two genes, CTSW and LARS2, and the association with SNPs in their
cis region (i.e. less than 1000,000 base pairs from the target gene).
We first estimated coefficients βˆsj and standard errors for each SNP j for each tumor tissue s
from linear regression models, adjusted for sex, age and the top five principle component scores,
and obtained phenotype-specific estimates Ωˆs for genotype correlations in (4). We then computed
standard meta analytic tests, TQHetmeta, T
L
Hetmeta, and T
Q
Mix and T
L
Mix under the mixture model based
on the tissue specific βˆs, Σˆs and Ωˆs.
Results for the CTSW gene are presented in Table 3 for the LD threshold 0.5 and in Supplemental
Table S7 for the LD threshold 0.75. The number of cis-SNPs analyzed for the individual tissues
ranged from 30 to 41. Based on TLs , the KIRC, LGG, LUSC, UCEC tissues had p-values < 0.05,
but no significant associations after a multiple testing correction. When we tested using the strong
null model neither TLHetmeta nor T
L
Mix detected any statistical significant associations model for
any of seventeen tissues. In contrast, TQs detected statistically significant associations (even using
a Bonferroni threshold 0.05/17 ≈ 0.003) with the region for the BLCA, BRCA, LAML, LGG,
LUAD, LUSC, and OV tissues. Both, TQHetmeta and T
Q
Mix detected an overall association. Estimated
posterior probabilities pˆs > 0.75 were observed for multiple tissues (BLCA, BRCA, KIRP, LAML,
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LGG, LUAD, LUSC ,OV, PRAD, and SKCM) tissues, and suggestive evidence was provided for two
tissues, UCEC and LIHC (with posterior probabilities pˆs of 0.61 and 0.45, respectively). We note
that three tissues (KIRP, PRAD and SKCM) had individual study p-values > 0.003, but posterior
probabilities pˆs > 0.80 (Table 3). Two of these tissues had small sample sizes, highlighting that small
studies sometimes borrow more information from the overall set of studies. We also note that the
p-value from the KIRC tissue was similar to that for the PRAD tissue (both approximately equal to
0.04); however, the posterior probability estimate for this tissue was pˆs ≈ 0. Our approach lessened
the importance of large studies with weak evidence. The parameter estimates in the mixture model
were pˆi = 0.61 for the proportion of associated studies, Ê(µ) = −0.0058 and Ê(µ3c) = 6×10−5 for the
mean genetic effect sizes, and eψˆ = 0.008 and eζˆ = 7×10−5 for the mean values of the heterogeneity
parameters. The small value of µˆ indicates that the signal is sparse and heterogeneous in the region.
Results for the eQTL data for the seventeen tissues and SNPs from the LARS2 gene are presented
in Supplemental Tables S8 and S9. The linear tests TLHetmeta an T
L
Mix did not detect an association
between tissues and LARS2, while both quadratic testd did. Based on TQ, the posterior probabilities
for all tissues were equal to one. The parameter estimates in the mixture model were pˆi = 1 for the
proportion of associated studies, Ê(µ) = 0.03 and Ê(µ3c) = 0.00002 for the mean values of the genetic
effect sizes, and eψˆ = 0.001 and eζˆ = 8.5×10−4 for the mean values of the heterogeneity parameters.
Large values of these parameters indicate that a single density with heavy tails is the best fit to the
data. Therefore, our approach may have lower specificity when the proportion of associated studies
and estimated effects are heterogeneous as indicated by a large posterior probability for the PAAD
tissue, which had a marginal p-value of 0.41.
For this example, we did not test under the weak null model as we did not have knowledge about
a negative control study.
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Table 3: Results from cross-tissue eQTLs association analysis with cis-SNPs, CTSW gene. The
sample size is the number of measurements for the specific tissue. The number of SNPs (#) is the
number of SNPs in the cis region with MAF > 5% and pairwise LD < 50%. Posterior probabilities
were calculated for TLMix and T
Q
Mix and p-values for T
L
Hetmeta and T
Q
Hetmeta under a single density, ϕ0.
Linear Test, TL Quadratic Test, TQ
Cancers Sample
size
#
SNPs
PosteriorP-value Posterior P-value
BLCA 266 37 0.46 6.08E-02 1 1.45E-05
BRCA 713 39 0.00 3.70E-01 1 1.71E-13
COAD 186 40 0.07 9.31E-01 0.03 5.79E-01
GBM 120 38 0.01 9.22E-01 0.06 8.42E-01
HNSC 351 35 0.00 2.84E-01 0.00 9.44E-02
KIRC 390 34 0.38 4.63E-02 0.00 3.98E-02
KIRP 92 32 0.21 7.13E-01 0.82 6.13E-02
LAML 154 30 0.42 2.12E-01 1.00 6.78E-04
LGG 326 36 0.28 4.53E-02 1.00 2.88E-04
LIHC 75 41 0.20 9.43E-01 0.45 2.69E-01
LUAD 427 33 0.01 9.03E-02 1 7.28E-08
LUSC 407 38 0.02 5.83E-03 1 1.15E-08
OV 219 36 0.22 8.02E-02 1.00 2.94E-03
PAAD 149 36 0.15 8.70E-01 0.03 7.74E-01
PRAD 153 39 0.30 7.21E-01 0.84 3.76E-02
SKCM 354 40 0.11 7.45E-02 0.97 5.72E-03
UCEC 268 39 0.61 4.85E-02 0.61 1.15E-01
TLMix T
L
Hetmeta T
Q
Mix T
Q
Hetmeta
Global
P-value
0.50 3.37E-01 <0.001 2.81E-14
BLCA: Bladder Urothelial Carcinoma; BRCA: Breast invasive car-
cinoma; COAD: Colon adenocarcinoma; GBM: Glioblastoma multi-
forme; HNSC: Head and Neck squamous cell carcinoma;KIRC: Kid-
ney renal clear cell carcinoma; KIRP: Kidney renal papillary cell
carcinoma; LAML: Acute Myeloid Leukemia; LGG: Brain Lower
Grade Glioma; LIHC: Liver hepatocellular carcinoma; LUAD: Lung
adenocarcinoma; LUSC: Lung squamous cell carcinoma; OV: Ovar-
ian serous cystadenocarcinoma; PAAD: Pancreatic adenocarcinoma;
PRAD: Prostate adenocarcinoma; SKCM: Skin Cutaneous Melanoma;
UCEC: Uterine Corpus Endometrial Carcinoma
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5 Simulations
5.1 Setup
We assessed the type 1 error and the power of the mixture method for both binary and continuous
outcomes, Ys. To generate realistic patterns of LD, we used genotypes of common SNPs (MAF≥
5%) on chromosome 6 observed in the 4631 controls from the glioma study (Rajaraman and others ,
2012) also used in Section 4.1. We applied LD pruning to ensure that the maximal pairwise LD
between SNPs was no larger than 0.5. For each setting we generated S = 20 studies, of which
SC = 0, 1, 5, 10 and 15 studies had SNPs associated with Ys. We investigated two LD patterns.
For the “high LD pattern” setting we used genotypes for 210 common SNPs in the region from
29600054bp to 31399945bp on chromosome 6 (HLA I class region). For the “low LD pattern”, we
selected p = 210 SNPs in the region from 110391bp to 1525603b on chromosome 6 with pairwise LD
smaller than 0.5. We also studied the impact of sample size of the studies with no signal on power.
For binary Ys, the sample size for studies with truly associated SNPs was N
1
case = N
1
cont = 2500,
and the sample sizes of studies with no signal was N0case = N
0
cont = 3500, N
0
case = N
0
cont = 2500 and
N0case = N
0
cont = 1500. For continuous outcomes, the sample size for studies with causal SNPs was
N1 = 5000, and for studies with no signal was N0 = 7000, N0 = 5000 and N0 = 3000.
For studies under the strong null model, we generated N = 5000 phenotypes Ysi from N(0, 1)
and for binary Ys, we randomly assigned 2500 cases and 2500 controls to 5000 genotypes. For the Sc
studies with truly associated SNPs, we randomly selected pC = 11 of the p = 210 SNPs and gener-
ated γsj for j = j1, ..., j11 in model (1) from generated N(µsj, τsj), where µsj ∼ N {E(µ), (E(µ)/4)2}
and τsj ∼ TN {E(τ), (E(τ)/2)2} where TN denotes a normal distribution truncated at 0. Continu-
ous phenotypes were generated from Yis = γ
′
sX is+esi, where esi ∼ N(0, 1). For simulations based on
case control data, we generated Ys ∼ Bernoulli(qs), where qs = exp(γ0 + γ ′sX is)/ {1 + exp(γ0 + γ ′sX is)}
with γ0 = log(0.01/0.99) for a large cohort and then sampled cases and controls.
Under the weak null model for null SNPs, we generated γsj from γsj ∼ N(0, τsj) and τsj ∼
TN {E(τ), (E(τ)/2)2} for s = 1, ..., 20. For the SC studies with pC = 11 randomly selected truly
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associated SNPs, we generated γj for j = j1, ..., j11 using the hierarchical structure in Figure 1.
For both, the strong and weak null models, we investigated the type 1 error (SC = 0) and the
power of TLMix and T
Q
Mix for SC = 1, 5, 10 and 15. We used two estimates for the matrix Ωs of
correlations among SNPs, in (4): 1) a global external estimate obtained from the original 4250
original controls and 2) and internal estimates obtained separately for each study (Ωˆs, s = 1, ..., 20)
based on the observed genotypes.
We compared the power of TLMix and T
Q
Mix to that of T
L
Hetmeta and T
Q
Hetmeta in (19) and (20), and
additionally to the sum of Hotelling tests, THotmeta =
∑S
s=1 βˆ
∗′
s Σ
∗−1
s βˆ
∗
s. The asymptotic distributions
for these tests are calculated under the strong null model (Tang and Lin, 2014; Lee and others , 2013).
For TLHetmeta and T
Q
Hetmeta, we used a LRT similar to that used for the mixture models for T
L
Mix and
TQMix, but with pi = 1 under the alternative model.
5.2 Simulation results
5.2.1 Type 1 error for testing for heterogeneity of associations
The empirical type 1 error rates for our TLMix and T
Q
Mix with binary and continuous outcomes are
presented in detail in Supplemental Tables S2 and S3 for α = 0.05 and α = 0.01, for testing under
the strong and weak null models. The mixture model with TLMix had the nominal type 1 error,
regardless of the LD pattern, type of estimate of Ωs or type of null model. For the mixture model
with TQMix when LD was low, the empirical type 1 error was slightly conservative for both internal
and external estimates of Ωs. However, when LD was high, the empirical type 1 error estimates
were more conservative for both null models for external estimates of Ωs that do not capture LD
patterns as accurately as internally estimated Ωs. Overall our empirical results confirm that the
type 1 error is controlled when ps is large.
5.2.2 Power to test under the strong null model
Here, we focus on findings for binary Ys. Results for continuous Ys were qualitatively similar and are
presented in Supplemental Figures S8 and S9. The results from our power studies are summarized
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in Figure 2, Supplemental Figures S1 - S5. The mixture approach had better power than other
methods (Figure 2, Supplemental Figures S1 - S5 ) when the proportion of studies with associated
SNPs was below 50%. When the proportion of studies with signal was above 50%, TLHetmeta and
TQHetmeta had better power than T
L
Mix and T
Q
Mix (Supplemental Figures S1 - S5). For the same
settings, the linear tests, TLMix and T
L
Hetmeta had higher power when effect sizes were small and in
the same directions (Supplemental Figures S1 - S3). But, as expected they were not powerful when
the genetic effects were heterogeneous (Figure 2 and Supplemental Figures S1 - S5). The empirical
power of TQMix and T
L
Mix was not noticeably affected by the sample size of studies not associated
with the region. Similarly, THotmeta was not affected by the sample size of the null studies, because
it explicitly assigns the same weight to each study. In contrast, the power of TQHetmeta was higher
when the sample sizes of the studies with associated SNPs were larger than those with no signal
(Supplemental Figures S2 - S3). We saw similar results for the eQTL data and SNPs from the
LARS2 gene (Section 4.2) When LD in a region was high, using external estimates for Ωs resulted
in more conservative Type 1 error and thus decreased of power of TQMix and slightly lower power of
TLMix. When Ωs was estimated from study specific data, the power of tests was similar regardless
of LD pattern (Figure 2, Supplemental Figures S1 - S5 ).
5.2.3 Power to test under the weak null model
Similarly to testing under the strong null model, the LD pattern did not noticeably impact the power
when Ωs was estimated internally (Figure 3, Supplemental Figures S6 and S7). The quadratic test
statistic TQMix had higher power than all other tests when the proportion of studies with associated
SNPs was small (Figure 3). However, the power of TQMix dropped noticeably when more than 50%
studies had associated SNPs, was depended on sample sizes of the studies with causal SNPs (Figure
3, Supplemental Figures S6 and S7). The reason for this loss of power is that when E(µ) is large,
the variance of the component density ϕ1 of the mixture (11) is much larger than the variance
for ϕ0, which makes it challenging to identify heterogeneity of associations, as a single component
density may fit the observed data as well as the mixture. Similarly, TQHetmeta had low power for
all simulation scenarios under the weak null (Figure 3). The power of the linear tests under both,
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Figure 2: Empirical power comparisons for binary phenotypes between various methods for testing
the strong null model (µ ≡ 0, τ ≡ 0). Low LD pattern between SNPs in a region; sample sizes per
study without and with signal are N0case = N
0
cont = 3500, N
1
case = N
1
cont = 2500. T
Q
Mix Ω and T
L
Mix Ω
use external estimate of matrix Ω. Level of the test is 0.05 and S = 20 studies are analyzed. Panel
A: SNP effects under alternative E(µ) 6= 0 and τ ≡ 0; Panel B: SNP effects under alternative
E(µ) = 0.05 and E(τ) 6= 0.
the mixture and single component density models, increased as the number of studies with signal
increased (Figure 3), because ϕ0 has mean equal to 0 under the null model. Lastly, the power for
testing under the weak null model was much higher when the null studies had larger sample sizes,
because they provide more information on the true amount of heterogeneity captured by τ .
6 Discussion
We proposed a novel approach based on a mixture model to assess the heterogeneity of associations
of genetic variation in a pre-specified region with different phenotypes, and to identify the subset
of phenotypes associated with the region. Our simulations and a data example using eQTL data
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Figure 3: Empirical power comparisons for binary phenotypes between various methods for testing
the weak null model (µ ≡ 0). Sample sizes per study without and with signal are N0case = N0cont =
3500, N1case = N
1
cont = 2500. T
Q
Mix Ω and T
L
Mix Ω use external estimate of matrix Ω. Level of the
test is 0.05 and S = 20 studies are analyzed. Panel A: Low LD pattern between SNPs in a region
Panel B: High LD pattern between SNPs in a region.
show that when the proportion of associated phenotypes is less than 50%, combining region specific
estimates using a quadratic test statistic under the mixture model assumption had much better
power to identify truly associated outcomes than standard meta analytic approaches. However,
when the proportion of associated outcomes was high, standard meta analytic methods were more
powerful than our approach. Similar conclusions were previously reached in the context of testing
rare variants, where using linear tests with data driven weights worked well when the proportion
of variants with signal was low, but a simple sum test had better power when the proportion was
high (Derkach and others , 2014).
There are many tests for associations between a genetic region and a single phenotype for com-
mon (e.g. Zaykin and others , 2002; Van der Sluis and others , 2015) and rare SNPs (e.g. Neale and
others , 2011; Lee and others , 2012). Aggregated level methods for common variants for testing gene-
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and pathway level associations typically are based on p-values (Van der Sluis and others , 2015).
Few methods exist to assess cross-phenotype associations using summary statistics. Bhattacharjee
and others (2012) extended fixed effects meta analysis for a single SNP by allowing some subsets
of outcomes to have no associations. Our method expands this work in two ways. First, we aggre-
gate association estimates from multiple SNPs measured in a region, and thus utilize information
stemming from LD. We also quantify heterogeneity between associations for different phenotypes.
Another advantage of our approach is that it allows one to incorporate prior or external information
on the likelihood that a phenotype exhibits associations with a region via the mixing proportion,
which can improve identification of associated outcomes. Our framework also extends a recently
proposed Bayesian method (CPBayes) for testing the association between a single SNP and multiple
phenotypes (Majumdar and others , 2017). CPBayes imposes a spike and slab prior on the genetic
SNP effect and uses a mixture of two normal distributions to represent the SNP effect under the null
and alternative models. When a single SNP is analyzed, our mixture set up corresponds to that of
CPBayes. However, we additionally estimate the amount of heterogeneity between outcome specific
associations, captured by the parameter τ , directly from the data, while in Majumdar and others
(2017) it is pre-specified. Mis-specifying the amount of heterogeneity will lower power, sensitivity
and specificity of the procedure in Majumdar and others (2017).
Our approach also differs from other recently proposed methods for gene-based testing that
require phenotypes to be measured on the same individuals to estimate between phenotype cor-
relations (Van der Sluis and others , 2015; Tang and Ferreira, 2012; Kwak and Pan, 2017). For
cancer outcomes one could simply assume outcomes are uncorrelated, as it is exceedingly unlikely
to be diagnosed with two primary cancers and apply these methods to the summary statistics from
multiple studies to test whether there is at least one study that shows associations. However, these
methods cannot identify which particular outcomes are associated with the SNPs in a gene/region.
Our work extends beyond testing the presence of any association between SNPs in a region for
multiple outcomes. Using the weak null model, we also assess if associations are due to common
signal or due to heterogeneity. A limitation is that to test under the weak null model, we require
availability of a study without association. This control phenotype study helps distinguish between-
24
study heterogeneity from true underlying associations. Another limitation of our method is that if
study specific estimates of Ωs are not available, one needs to use publicly available genetic data such
as 1000 Genomes Project Consortium (2010) to estimate Ωs, which results in somewhat including
lower power.
Several problems remain to be addressed in future work, handling shared controls between
studies and more efficient permutation approaches to compute p-values for our model.
7 Software
Software in the form of R code, together with a sample input data set and complete documentation
is available at
https://github.com/derkand/STAMP.
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